Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation
Details
Publication Year 2021-07-27, Volume 118, Issue #30, Page e2103518118
Journal Title
Proceedings of the National Academy of Sciences of the United States of America
Abstract
Insulin-signaling requires conformational change: whereas the free hormone and its receptor each adopt autoinhibited conformations, their binding leads to structural reorganization. To test the functional coupling between insulin's "hinge opening" and receptor activation, we inserted an artificial ligand-dependent switch into the insulin molecule. Ligand-binding disrupts an internal tether designed to stabilize the hormone's native closed and inactive conformation, thereby enabling productive receptor engagement. This scheme exploited a diol sensor (meta-fluoro-phenylboronic acid at Gly(A1)) and internal diol (3,4-dihydroxybenzoate at Lys(B28)). The sensor recognizes monosaccharides (fructose > glucose). Studies of insulin-signaling in human hepatoma-derived cells (HepG2) demonstrated fructose-dependent receptor autophosphorylation leading to appropriate downstream signaling events, including a specific kinase cascade and metabolic gene regulation (gluconeogenesis and lipogenesis). Addition of glucose (an isomeric ligand with negligible sensor affinity) did not activate the hormone. Similarly, metabolite-regulated signaling was not observed in control studies of 1) an unmodified insulin analog or 2) an analog containing a diol sensor without internal tethering. Although secondary structure (as probed by circular dichroism) was unaffected by ligand-binding, heteronuclear NMR studies revealed subtle local and nonlocal monosaccharide-dependent changes in structure. Insertion of a synthetic switch into insulin has thus demonstrated coupling between hinge-opening and allosteric holoreceptor signaling. In addition to this foundational finding, our results provide proof of principle for design of a mechanism-based metabolite-responsive insulin. In particular, replacement of the present fructose sensor by an analogous glucose sensor may enable translational development of a "smart" insulin analog to mitigate hypoglycemic risk in diabetes therapy.
Keywords
diabetes mellitus; hormone–receptor recognition; insulin pharmacology; protein engineering; receptor tyrosine kinase
WEHI Research Division(s)
Structural Biology
PubMed ID
34290145
Rights Notice
Refer to copyright notice on published article.


Creation Date: 2021-08-16 10:40:36
Last Modified: 2021-08-16 10:52:08
An error has occurred. This application may no longer respond until reloaded. Reload 🗙